Department of Computer Science, University of Oxford

From National Security to Cartel Infiltration -- Ciaran Martin and Robert Mazur to Keynote (ISC)² Security Congress 2022 in Las Vegas

Retrieved on: 
Wednesday, August 3, 2022

ALEXANDRIA, Va., Aug. 3, 2022 /PRNewswire/ -- (ISC)² – the world's largest nonprofit association of certified cybersecurity professionals – today announced Ciaran Martin and Robert Mazur as keynote speakers at the 2022 (ISC)² Security Congress in Las Vegas and live online. Both Martin and Mazur's keynotes will be on day two of the conference, taking place October 10-12.

Key Points: 
  • "Ciaran Martin's achievements as head of the UK National Cyber Security Centre are world-renowned," said Clar Rosso, CEO, (ISC).
  • Robert Mazur is one of the world's leading experts on the financial exploits of the underworld.
  • "Robert Mazur's keynote will provide Security Congress attendees with first-hand insights into the motivations and tactics of threat actors throughout the criminal underworld,"said Rosso.
  • 2022 (ISC) Inc., (ISC), CISSP, SSCP, CCSP, CAP, CSSLP, HCISPP, CISSP-ISSAP, CISSP-ISSEP, CISSP-ISSMP and CBK are registered marks of (ISC), Inc.

Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments

Retrieved on: 
Thursday, March 31, 2022

OXFORD, England, March 31, 2022 /PRNewswire/ -- Oxford Science Enterprises, the Science Business Builder and preferred investment partner of the University of Oxford, today announces further strengthening of its investment teams with the appointments of Heather Roxborough PhD as Partner, Health Tech and Wallace Wallace MPhil as Associate, Life Sciences.

Key Points: 
  • - Heather Roxborough PhD, former Partner at Optum Ventures, joins as Partner, Health Tech
    OXFORD, England, March 31, 2022 /PRNewswire/ --Oxford Science Enterprises, the Science Business Builder and preferred investment partner of the University of Oxford, today announces further strengthening of its investment teams with the appointments of Heather Roxborough PhD as Partner, Health Tech and Wallace Wallace MPhil as Associate, Life Sciences.
  • Alexis Dormandy, CEO Oxford Science Enterprises, said:"I am thrilled to welcome Heather and Wallace.
  • Wallace joins Oxford Science Enterprises from M-Ventures, the corporate venture capital arm of Merck KGaA, where she supported the life sciences investment team across scientific due diligence and portfolio management.
  • We are Oxford Science Enterprises, the Science Business Builder.

Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments

Retrieved on: 
Thursday, March 31, 2022

OXFORD, England, March 31, 2022 /PRNewswire/ -- Oxford Science Enterprises, the Science Business Builder and preferred investment partner of the University of Oxford, today announces further strengthening of its investment teams with the appointments of Heather Roxborough PhD as Partner, Health Tech and Wallace Wallace MPhil as Associate, Life Sciences.

Key Points: 
  • - Heather Roxborough PhD, former Partner at Optum Ventures, joins as Partner, Health Tech
    OXFORD, England, March 31, 2022 /PRNewswire/ --Oxford Science Enterprises, the Science Business Builder and preferred investment partner of the University of Oxford, today announces further strengthening of its investment teams with the appointments of Heather Roxborough PhD as Partner, Health Tech and Wallace Wallace MPhil as Associate, Life Sciences.
  • Alexis Dormandy, CEO Oxford Science Enterprises, said:"I am thrilled to welcome Heather and Wallace.
  • Wallace joins Oxford Science Enterprises from M-Ventures, the corporate venture capital arm of Merck KGaA, where she supported the life sciences investment team across scientific due diligence and portfolio management.
  • We are Oxford Science Enterprises, the Science Business Builder.

Artificial Intelligence Improves Coronary Artery Disease Detection, New Study Finds

Retrieved on: 
Thursday, December 16, 2021

OXFORD, England, Dec. 16, 2021 /PRNewswire/ --A new study published today , Automated Echocardiographic Detection of Severe Coronary Artery Disease Using Artificial Intelligence , found that Ultromics' EchoGo platform, powered by Artificial Intelligence (AI), significantly improved the accuracy and confidence in coronary artery disease (CAD) detection from a stress echocardiogram.

Key Points: 
  • OXFORD, England, Dec. 16, 2021 /PRNewswire/ --A new study published today , Automated Echocardiographic Detection of Severe Coronary Artery Disease Using Artificial Intelligence , found that Ultromics' EchoGo platform, powered by Artificial Intelligence (AI), significantly improved the accuracy and confidence in coronary artery disease (CAD) detection from a stress echocardiogram.
  • Ultromics' has developed an AI algorithm that automatically analyzes stress echocardiograms and tells the clinician whether that patient is at risk of coronary artery disease.
  • During the first portion of the study, Ultromics AI was trained and tested to identify patients with severe coronary artery disease.
  • The fact that we can now apply artificial intelligence to echocardiography to perform at this level is truly revolutionary for patient care".

Artificial Intelligence Improves Coronary Artery Disease Detection, New Study Finds

Retrieved on: 
Wednesday, December 15, 2021

OXFORD, England, Dec. 15, 2021 /PRNewswire/ --A new study published today , Automated Echocardiographic Detection of Severe Coronary Artery Disease Using Artificial Intelligence , found that Ultromics' EchoGo platform, powered by Artificial Intelligence (AI), significantly improved the accuracy and confidence in coronary artery disease (CAD) detection from a stress echocardiogram.

Key Points: 
  • OXFORD, England, Dec. 15, 2021 /PRNewswire/ --A new study published today , Automated Echocardiographic Detection of Severe Coronary Artery Disease Using Artificial Intelligence , found that Ultromics' EchoGo platform, powered by Artificial Intelligence (AI), significantly improved the accuracy and confidence in coronary artery disease (CAD) detection from a stress echocardiogram.
  • Ultromics' has developed an AI algorithm that automatically analyzes stress echocardiograms and tells the clinician whether that patient is at risk of coronary artery disease.
  • During the first portion of the study, Ultromics AI was trained and tested to identify patients with severe coronary artery disease.
  • The fact that we can now apply artificial intelligence to echocardiography to perform at this level is truly revolutionary for patient care".

MUFG Investor Services Joins Groundbreaking Oxford Study On Career Advancement

Retrieved on: 
Tuesday, October 19, 2021

An impactful new study is tracking the role of career advancement coaching to do just this, and corporations are getting on board.

Key Points: 
  • An impactful new study is tracking the role of career advancement coaching to do just this, and corporations are getting on board.
  • The nine-month study will be conducted by the University of Oxford's Kellogg College to investigate attitudes towards career advancement among young professional employees and the impact of coaching interventions on performance, engagement, and career advancement.
  • "We're delighted to welcome a truly progressive employer like MUFG Investor Services to our Corporate Research Program," said CareerPoint Founder and CEO Steve McIntosh.
  • It's exciting to partner with industry leaders like MUFG Investor Services and a center of academic excellence like Oxford to advance society's understanding in this very important area."

Cambridge Quantum Appoints Professor Stephen Clark as Head of Artificial Intelligence

Retrieved on: 
Monday, April 12, 2021

b'CAMBRIDGE, England, April 12, 2021 /PRNewswire/ -- Cambridge Quantum Computing ( CQC ) are pleased to announce the appointment of Prof. Stephen Clark as Head of Artificial Intelligence.

Key Points: 
  • b'CAMBRIDGE, England, April 12, 2021 /PRNewswire/ -- Cambridge Quantum Computing ( CQC ) are pleased to announce the appointment of Prof. Stephen Clark as Head of Artificial Intelligence.
  • Prof. Clark joins CQC from DeepMind where he was a Senior Staff Research Scientist and led a team working on grounded language learning in virtual environments.
  • Before that, Prof. Clark was a member of faculty at the Oxford University Department of Computer Science, and a Fellow of Keble College, Oxford.
  • Clark said, "I am delighted to be joining Cambridge Quantum, a cutting-edge world-leading quantum computing company.

Cambridge Quantum Appoints Professor Stephen Clark as Head of Artificial Intelligence

Retrieved on: 
Monday, April 12, 2021

b'CAMBRIDGE, England, April 12, 2021 /PRNewswire/ -- Cambridge Quantum Computing ( CQC ) are pleased to announce the appointment of Prof. Stephen Clark as Head of Artificial Intelligence.

Key Points: 
  • b'CAMBRIDGE, England, April 12, 2021 /PRNewswire/ -- Cambridge Quantum Computing ( CQC ) are pleased to announce the appointment of Prof. Stephen Clark as Head of Artificial Intelligence.
  • Prof. Clark joins CQC from DeepMind where he was a Senior Staff Research Scientist and led a team working on grounded language learning in virtual environments.
  • Before that, Prof. Clark was a member of faculty at the Oxford University Department of Computer Science, and a Fellow of Keble College, Oxford.
  • Clark said, "I am delighted to be joining Cambridge Quantum, a cutting-edge world-leading quantum computing company.